Efficacy and safety of ifupinostat (BEBT-908) in combination with rituximab for relapsed/refractory diffuse large B-cell lymphoma: Results from an exploratory phase Ib study.

Authors: Peng Liu, Yufu Li, Yajun Li, Fang Zhu, Ying Cheng, Ou Bai, Wenyu Li, Hui Wu, Xinquan Liang, Yongdong Zhang, Hongwei Xue, Zhiming Li, Changgeng Qian, Yuankai Shi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.7050

Source: Full article

---

Abstract

7050